Pharmaceutical Industry Business Confidence Report H1 2016

Category : Pharmaceuticals  | Published Date : March-2016 | Pages : 49
The existing economic environment is stable for the pharmaceutical industry, and customer confidence levels will remain constant in H1 2016 (January 2016-June 2016). Companies are slightly optimistic about economic conditions in North America and Asia-Pacific due to positive momentum in the US manufacturing and production sectors, firm domestic demand, strong government expenditure in India, and robust private consumption and export growth in South Korea and Vietnam. Over the next six months the industry will increase its expenditure towards new product development and IT infrastructure. Moreover, companies operating in Asia-Pacific forecast their budget allocation for pharmaceutical equipment to increase significantly in 2016, compared to 2015.

Key Findings
In total, 43% of pharmaceutical industry business executives expect the global economy to be stable in H1 2016 (January 2016-June 2016). Furthermore, 33% of survey respondents anticipate a favorable or very favorable economic environment

Overall, 83% of respondents who operate in Europe are optimistic over company growth prospects, while no executives anticipate a negative impact on the industry in the region

Business executives operating in the Rest of the World region anticipate the highest increase in staff headcount growth over the next six months

In H1 2016, the majority of business executives from North America are concerned about the performance of North American economies, the performance of the Eurozone, and cyber crime

Survey results reveal that 41% of pharmaceutical industry respondents who operate in Asia-Pacific expect an increase of 1-5% in the budget for pharmaceutical equipment during 2016

Kables pharmaceutical Industry Business Confidence Survey H1 2016 examines executives opinion on the business environment over January-June 2016. It also highlights existing economic conditions, supplier price variations, sales performance, industry and company growth outlook, spending patterns, and key priorities. Additionally, the report includes trends in the pharmaceutical equipment market, analysis of the procurement budget allocations, and leading suppliers of pharmaceutical equipment.

What else does this report offer?

Current state of the global economy: examines prevailing economic conditions globally and across various regions

Company and industry growth outlook: provides industry executives expectations towards the growth prospects of their company and the industry over the next six months

Change in customer confidence: analyzes pharmaceutical industry executives opinion about the change in customer confidence during H1 2016

Supplier prices projection: determines expected change in supplier prices across various categories and their impact on business confidence

Change in staff headcount and sales performance: tracks expected change in staff headcount and sales for H1 2016 among industry executives globally

Significant investment activities: highlights various areas in which industry executives intend to invest over the next six months

Business concerns: provides information about potential business concerns indicated by survey respondents for H1 2016

Key priorities: identifies the top priorities of industry executives operating in various regions

Purchase preferences: analyzing the purchasing behavior towards pharmaceutical equipment and investment allocations in the pharmaceutical equipment categories

Budget allocation: examining total procurement budget split between capital expenditure and operating expenditure, and tracking the changes in the budget for 2015 and expectations for 2016

Reasons To Buy
Helps organizations to make effective business strategy decisions by knowing the prevailing business conditions and sentiment within the pharmaceutical industry

Organizations will be supported in business expansion decisions by providing information about projected change in sales performance and supplier prices

Helps to improve operational efficiency of the organization by knowing about key priorities and the main concerns of pharmaceutical industry executives

Helps to alter investment allocation by understanding key focus areas highlighted by survey respondents during H1 2016

Enables organizations to make key decisions on purchase preferences and investments in pharmaceutical equipment
Table Of ContentsIntroduction 
Methodology and sample size
Respondent profile

Economic State, growth prospects and customer confidence
Existing economic environment
Industry and company growth outlook
Expected change in customer confidence

Supplier prices, staff headcount and sales performance
Supplier prices expectations
Anticipated change in staff head count and sales projections
Anticipated change in spend on key activities

Business concerns and organizational priorities
Level of concerns and expected impact
Significance of potential business priorities

Procurement budget and expenditure outlook
Purchase preferences for pharmaceutical equipment
Frequency of investments towards various equipment categories
Procurement of number of pieces of equipment
Average expenditure per purchase
Allocation of investment for equipment purchases
Distribution of procurement budget between capital and operating expenditure
Change in procurement budget expenditure
Variation in pharmaceutical equipment budget from 2015 to 2016
Leading suppliers across pharmaceutical equipment types

AppendixList Of TablesN/AList Of FiguresFigure 1: Current economic condition Overall
Figure 2: Current economic condition Region
Figure 3: Current economic condition Those who operate and do not operate in a region
Figure 4: Industry and company growth prospects Overall
Figure 5: Industry and company growth prospects Overall In detail
Figure 6: Industry and company growth prospects Region
Figure 7: Anticipated variation in customer confidence Overall
Figure 8: Anticipated variation in customer confidence Region
Figure 9: Projected change in supplier prices Raw Materials Overall and regional
Figure 10: Projected change in supplier prices Semi-finished products Overall and regional
Figure 11: Projected change in supplier prices Packaging Overall and regional
Figure 12: Projected change in supplier prices Ingredients Overall and regional
Figure 13: Staff headcount and sales outlook Regional
Figure 14: Expenditure projection on key activities Overall
Figure 15: Top five business concerns Region
Figure 16: Business concerns Overall and regional
Figure 17: Business concerns Overall and regional
Figure 18: Top five organizational priorities Region
Figure 19: Organizational priorities Overall and region
Figure 20: Purchase preferences Region
Figure 21: Frequency of investments Overall
Figure 22: Procurement of number of pieces of equipment Overall
Figure 23: Average expenditure per purchase Overall
Figure 24: Investment allocation for equipment purchases Region
Figure 25: Distribution of procurement budget Region
Figure 26: Change in procurement budget expenditure Region
Figure 27: Change in pharmaceutical equipment budget Region
Figure 28: Leading suppliers across pharmaceutical equipment types Overall
Publisher Name : Kable Market Research

Published Reports
About Spinal Fusion Spinal fusion surgery is performed in many forms, and all are designed to help limit the pain caused by joints through surgery depending on conditions such as degenerative disc disease (DDD), spondylosyndesis or spondylodesis, and other small problems caused in spine vertebrae. Spine ....
US $2500
About Cystic Fibrosis Cystic fibrosis, also known as mucoviscidosis, is a genetically inherited, chronic disease and is progressive in nature. The onset of cystic fibrosis typically occurs in early childhood or, rarely, at birth. The primary symptoms of cystic fibrosis include breathing difficulties, ....
US $2500
Summary Global Pharmaceuticals industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value 2011-15, and forecast to 2020). The profile also contains descriptions of the leading players including key financial metrics and analysis of ....
US $1495

Upcoming Reports
Clinical nutrition products are type of pharmaceutical products, which help to keep patient healthy. They aid to improve metabolic system of the body by providing adequate supplements such as minerals, vitamins and others .
US $ 4148
Increase in Abbreviated New Drug Applications (ANDA) over the past years has fostered the demand for API market. Furthermore, Indian companies making increased entries related to Drug Master File (DMF) indicates APIs market gaining traction .
US $ 4148
Asia-Pacific Nuclear Medicine/Radiopharmaceuticals & Stable Isotopes Market - Opportunities and Forecasts, 2014 - 2020
US $2850
Please Select Format
Single User: US $ 1950
Site User: US $ 3900
Enterprise User: US $ 5850

market research offer
Contact us
Call us +1-971-202-1575
--- or ---
With high quality and penned to perfection, Big Market Research is an exclusive online market to get best market research reports for your business needs and strategies. We recommend you to stop browsing as soon as you discover our website. This is because we firmly believe that once you reach here; all your business concerns will be addressed.

We have a huge collection of market research report from numerous filed which will provide you with all the necessary solution. We make sure that reports that we sell are true in context, have a quality that is unrivaled, fully integrated with equal spread of opinion. They will give you proper insights into different opportunities one may locate for their start-up pr expansion.

Let your qualms and concern be sidelined through our high end syndicated as well as customized reports.